Strober W
Mucosal Immunity Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Mucosal Immunol. 2008 Mar;1(2):92-5. doi: 10.1038/mi.2007.22. Epub 2008 Jan 16.
One of the chief requirements of an immune system, the mucosal immune system, that lies juxtaposed to a mass of potentially immunogenic commensal organisms is a well-developed mechanism to limit or negatively regulate nascent immune responses to those organisms. This mechanism, long subsumed under the name oral tolerance, is now understood to consist of a complex of factors, not the least of which is the ready ability to induce immunosuppressive regulatory T cells or Tregs. The emphasis here is on the "ability to induce" because the real individuality of the mucosal regulatory response lies not in the Tregs themselves, which after all can be induced anywhere and are mere tools of regulatory response. Now, as shown initially by the fact that oral tolerance is dependent on the size and mobility of its dendritic cell (DC) population, the individuality of the mucosal immune system is inherent in its inducing cells, i.e., the antigen-presenting DCs (or macrophages) of the mucosal immune system.(1, 2)Recently, new data have emerged that provide much more specific information on how mucosal DCs (or macrophages) are different in this respect and thus why they have a special tendency to facilitate the development of Tregs that then mediate oral tolerance. This is the subject of this brief review. The unresponsiveness of mucosal immune system to mucosal antigens is due to a process known as oral tolerance. Recent studies addressing the mechanism of such tolerance show that mucosal tissues are replete with a unique subset of dendritic cells that secrete factors such as, TGF-beta1 and retinoic acid, that induce foxp3+ regulatory T cells. Thus, we arrive at the somewhat surprising realization that mucosal unresponsiveness is, appropriately enough, related to the availability of a factor in the food stream.
免疫系统的主要需求之一是黏膜免疫系统,它与大量潜在具有免疫原性的共生生物相邻,因此需要一种完善的机制来限制或负向调节对这些生物的新生免疫反应。这种机制长期以来被统称为口服耐受,现在人们认识到它由一系列复杂因素组成,其中最重要的是诱导免疫抑制性调节性T细胞(Tregs)的现成能力。这里强调的是“诱导能力”,因为黏膜调节反应的真正独特之处并不在于Tregs本身,毕竟Tregs在任何地方都可以被诱导产生,它们只是调节反应的工具。现在,正如口服耐受依赖于其树突状细胞(DC)群体的大小和流动性这一事实最初所表明的那样,黏膜免疫系统的独特性在于其诱导细胞,即黏膜免疫系统的抗原呈递DC(或巨噬细胞)。(1, 2)最近,出现了新的数据,这些数据提供了更具体的信息,说明黏膜DC(或巨噬细胞)在这方面有何不同,以及为什么它们特别倾向于促进Tregs的发育,而Tregs随后介导口服耐受。这就是本简要综述的主题。黏膜免疫系统对黏膜抗原的无反应性是由于一种称为口服耐受的过程。最近关于这种耐受机制的研究表明,黏膜组织中充满了一种独特的树突状细胞亚群,它们分泌诸如转化生长因子-β1和视黄酸等因子,这些因子可诱导foxp3 +调节性T细胞。因此,我们得出了一个有点令人惊讶的认识:黏膜无反应性恰当地与食物流中一种因子的可用性有关。